Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (882)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Molecule	Drug Class / Mechanism	Oncology Type
Isatuximab	Anti-CD38 / SLAMF7 mAb	Hematologic (Multiple Myeloma)
Molecule Isatuximab Therapeutic Category Immunotherapy (Monoclonal Antibody) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
Itacitinib	JAK Inhibitor	Hematologic (MPN)
Molecule Itacitinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (MPN) Drug Class / Mechanism JAK Inhibitor
Ivosidenib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Ivosidenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Ixazomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Ixazomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Jaktinib	JAK Inhibitor	Hematologic (MPN)
Molecule Jaktinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (MPN) Drug Class / Mechanism JAK Inhibitor
Ladiratuzumab Vedotin	ADC	Solid Tumour
Molecule Ladiratuzumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Lanraplenib	SYK / Multi-Kinase Inhibitor	Hematologic
Molecule Lanraplenib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Lapatinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Lapatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Larotrectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Larotrectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Lazertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Lazertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Lerociclib	CDK Inhibitor	Solid Tumour
Molecule Lerociclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Lifileucel	Autologous Tumour-Infiltrating Lymphocyte (TIL) Therapy	Solid Tumour
Molecule Lifileucel Therapeutic Category Cellular Therapy Oncology Type Solid Tumour Drug Class / Mechanism Autologous Tumour-Infiltrating Lymphocyte (TIL) Therapy

Isatuximab Immunotherapy (Monoclonal Antibody)
Therapeutic Category Immunotherapy (Monoclonal Antibody) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
Itacitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (MPN) Drug Class / Mechanism JAK Inhibitor
Ivosidenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Ixazomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Jaktinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (MPN) Drug Class / Mechanism JAK Inhibitor
Ladiratuzumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Lanraplenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Lapatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Larotrectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Lazertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Lerociclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Lifileucel Cellular Therapy
Therapeutic Category Cellular Therapy Oncology Type Solid Tumour Drug Class / Mechanism Autologous Tumour-Infiltrating Lymphocyte (TIL) Therapy

‹ 1 … 44 45 46 47 48 … 74 ›

Product Range

Company

Global Network

Products

All Products (882)

Isatuximab

Itacitinib

Ivosidenib

Ixazomib

Jaktinib

Ladiratuzumab Vedotin

Lanraplenib

Lapatinib

Larotrectinib

Lazertinib

Lerociclib

Lifileucel

Isatuximab

Itacitinib

Ivosidenib

Ixazomib

Jaktinib

Ladiratuzumab Vedotin

Lanraplenib

Lapatinib

Larotrectinib

Lazertinib

Lerociclib

Lifileucel